We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Innovation Pharmaceuticals

News List

Innovation Pharmaceuticals Doses First Cohort of Oral Brilacidin for Ulcerative Colitis americanpharmaceuticalreview
January 19, 2020
Innovation Pharmaceuticals has dosed the first cohort in its Phase 1 trial to investigate the use of delayed release tablets for colonic delivery of Brilacidin in healthy volunteers. This study formally launches the Company’s clinical program in Ulcerativ
Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors From F biospace
December 28, 2017
Innovation Pharmaceuticals Announces Preliminary Results of Kevetrin's First Phase 2a Clinical Trial in Ovarian Cancer Therapy (see NCT03042702) Preliminary data encouraging.